Follow
yunhai li
yunhai li
the first affiliated hospital of chongqing medical university
Verified email at hospital.cqmu.edu.cn
Title
Cited by
Cited by
Year
Clinicopathological characteristics and breast cancer–specific survival of patients with single hormone receptor–positive breast cancer
Y Li, D Yang, X Yin, X Zhang, J Huang, Y Wu, M Wang, Z Yi, H Li, H Li, ...
JAMA network open 3 (1), e1918160-e1918160, 2020
1302020
PSMD2 regulates breast cancer cell proliferation and cell cycle progression by modulating p21 and p27 proteasomal degradation
Y Li, J Huang, B Zeng, D Yang, J Sun, X Yin, M Lu, Z Qiu, W Peng, ...
Cancer letters 430, 109-122, 2018
952018
Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer
Y Li, J Huang, D Yang, S Xiang, J Sun, H Li, G Ren
Oncology letters 15 (6), 9216-9230, 2018
692018
Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway
L Gan, Z Qiu, J Huang, Y Li, H Huang, T Xiang, J Wan, T Hui, Y Lin, H Li, ...
International Journal of Biological Sciences 12 (12), 1533, 2016
622016
Prevalence of thyroid nodules in China: a health examination cohort-based study
Y Li, C Jin, J Li, M Tong, M Wang, J Huang, Y Ning, G Ren
Frontiers in Endocrinology 12, 676144, 2021
452021
The transcription levels and prognostic values of seven proteasome alpha subunits in human cancers
Y Li, J Huang, J Sun, S Xiang, D Yang, X Ying, M Lu, H Li, G Ren
Oncotarget 8 (3), 4501, 2017
402017
Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer
B Zeng, Y Li, Y Feng, M Lu, H Yuan, Z Yi, Y Wu, T Xiang, H Li, G Ren
Biochemical and biophysical research communications 505 (1), 302-308, 2018
372018
CircEHMT1 inhibits metastatic potential of breast cancer cells by modulating miR-1233-3p/KLF4/MMP2 axis
M Lu, Y Wu, B Zeng, J Sun, Y Li, J Luo, L Wang, Z Yi, H Li, G Ren
Biochemical and Biophysical Research Communications 526 (2), 306-313, 2020
342020
Efficacy and safety of neoadjuvant chemotherapy regimens for triple-negative breast cancer: a network meta-analysis
Y Li, D Yang, P Chen, X Yin, J Sun, H Li, G Ren
Aging (Albany NY) 11 (16), 6286, 2019
292019
Downregulated CDKN1C/p57kip2 drives tumorigenesis and associates with poor overall survival in breast cancer
Z Qiu, Y Li, B Zeng, X Guan, H Li
Biochemical and biophysical research communications 497 (1), 187-193, 2018
262018
FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts
Y Wu, Z Yi, J Li, Y Wei, R Feng, J Liu, J Huang, Y Chen, X Wang, J Sun, ...
Theranostics 12 (10), 4564, 2022
242022
Meta-analysis of associations between DLG5 R30Q and P1371Q polymorphisms and susceptibility to inflammatory bowel disease
Y Li, P Chen, J Sun, J Huang, H Tie, L Li, H Li, G Ren
Scientific reports 6 (1), 33550, 2016
62016
Prognostic significance of CCL20 and its receptor CCR6 in cancers: a meta-analysis
Y Li, J Huang, H Tie, H Huang, H Li, G Ren
Int. J. Clin. Exp. Med 9, 1908-1919, 2016
52016
The system can't perform the operation now. Try again later.
Articles 1–13